Cocrystal Pharma, Inc. (COCP)
Nasdaq: COCP · CIK 0001412486 · United States
Every official Cocrystal Pharma, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open COCP filings
Cocrystal Pharma, Inc. documents
- Cocrystal Pharma, Inc. 10-K 2026COCP 10-K 2026: annual report for fiscal 2026
- Cocrystal Pharma, Inc. 10-K 2025COCP 10-K 2025: annual report for fiscal 2025
- Cocrystal Pharma, Inc. 10-K 2024COCP 10-K 2024: annual report for fiscal 2024
- Cocrystal Pharma, Inc. 10-K 2023COCP 10-K 2023: annual report for fiscal 2023
- Cocrystal Pharma, Inc. 10-K 2022COCP 10-K 2022: annual report for fiscal 2022
- Cocrystal Pharma, Inc. 10-Q 2026COCP 10-Q 2026: quarterly report for fiscal 2026
- Cocrystal Pharma, Inc. 10-Q 2025COCP 10-Q 2025: quarterly report for fiscal 2025
- Cocrystal Pharma, Inc. 10-Q 2024COCP 10-Q 2024: quarterly report for fiscal 2024
- Cocrystal Pharma, Inc. 10-Q 2023COCP 10-Q 2023: quarterly report for fiscal 2023
- Cocrystal Pharma, Inc. 10-Q 2022COCP 10-Q 2022: quarterly report for fiscal 2022
- Cocrystal Pharma, Inc. 8-K 2026COCP 8-K 2026: current report for fiscal 2026
- Cocrystal Pharma, Inc. 8-K 2025COCP 8-K 2025: current report for fiscal 2025
- Cocrystal Pharma, Inc. 8-K 2024COCP 8-K 2024: current report for fiscal 2024
- Cocrystal Pharma, Inc. 8-K 2023COCP 8-K 2023: current report for fiscal 2023
- Cocrystal Pharma, Inc. 8-K 2022COCP 8-K 2022: current report for fiscal 2022
- Cocrystal Pharma, Inc. DEF 14A 2026COCP DEF 14A 2026: proxy statement for fiscal 2026
- Cocrystal Pharma, Inc. DEF 14A 2025COCP DEF 14A 2025: proxy statement for fiscal 2025
- Cocrystal Pharma, Inc. DEF 14A 2024COCP DEF 14A 2024: proxy statement for fiscal 2024
- Cocrystal Pharma, Inc. DEF 14A 2023COCP DEF 14A 2023: proxy statement for fiscal 2023
- Cocrystal Pharma, Inc. DEF 14A 2022COCP DEF 14A 2022: proxy statement for fiscal 2022
- Cocrystal Pharma, Inc. Form 4 2026COCP Form 4 2026: insider trading filing for fiscal 2026
- Cocrystal Pharma, Inc. Form 4 2025COCP Form 4 2025: insider trading filing for fiscal 2025
- Cocrystal Pharma, Inc. Form 4 2024COCP Form 4 2024: insider trading filing for fiscal 2024
- Cocrystal Pharma, Inc. Form 4 2023COCP Form 4 2023: insider trading filing for fiscal 2023
- Cocrystal Pharma, Inc. Form 4 2022COCP Form 4 2022: insider trading filing for fiscal 2022
- Cocrystal Pharma, Inc. S-1 2026COCP S-1 2026: registration statement for fiscal 2026
- Cocrystal Pharma, Inc. S-1 2025COCP S-1 2025: registration statement for fiscal 2025
- Cocrystal Pharma, Inc. S-1 2024COCP S-1 2024: registration statement for fiscal 2024
- Cocrystal Pharma, Inc. S-1 2023COCP S-1 2023: registration statement for fiscal 2023
- Cocrystal Pharma, Inc. S-1 2022COCP S-1 2022: registration statement for fiscal 2022
- Cocrystal Pharma, Inc. 13F 2026COCP 13F 2026: institutional holdings for fiscal 2026
- Cocrystal Pharma, Inc. 13F 2025COCP 13F 2025: institutional holdings for fiscal 2025
- Cocrystal Pharma, Inc. 13F 2024COCP 13F 2024: institutional holdings for fiscal 2024
- Cocrystal Pharma, Inc. 13F 2023COCP 13F 2023: institutional holdings for fiscal 2023
- Cocrystal Pharma, Inc. 13F 2022COCP 13F 2022: institutional holdings for fiscal 2022
More companies